Commonwealth Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
1,214
+165
+16% +$169K 0.2% 81
2026
Q1
$965K Buy
1,049
+12
+1% +$12.2K 0.15% 84
2025
Q4
$1.11M Buy
1,037
+148
+17% +$142K 0.18% 75
2025
Q3
$678K Sell
889
-12
-1% -$8.93K 0.12% 99
2025
Q2
$702K Sell
901
-7
-0.8% -$5.44K 0.14% 90
2025
Q1
$750K Sell
908
-54
-6% -$44.9K 0.15% 88
2024
Q4
$743K Buy
962
+131
+16% +$108K 0.15% 82
2024
Q3
$735K Buy
831
+9
+1% +$8.09K 0.15% 81
2024
Q2
$755K Buy
822
+19
+2% +$15.2K 0.15% 78
2024
Q1
$468K Hold
803
0.11% 93
2023
Q4
$468K Buy
803
+6
+0.8% +$3.5K 0.11% 93
2023
Q3
$428K Buy
+797
New +$411K 0.13% 105
2017
Q1
$60K Hold
699
0.07% 91
2016
Q4
$54K Hold
699
0.05% 84
2016
Q3
$56K Sell
699
-390
-36% -$31.2K 0.05% 79
2016
Q2
$86K Hold
1,089
0.1% 73
2016
Q1
$78K Hold
1,089
0.12% 66
2015
Q4
$92K Hold
1,089
0.31% 57
2015
Q3
$91K Hold
1,089
0.11% 64
2015
Q2
$91K Hold
1,089
0.1% 71
2015
Q1
$79K Hold
1,089
0.07% 81
2014
Q4
$75K Buy
+1,089
New +$73.5K 0.07% 76

Other funds holding LLY

Commonwealth Financial Services's LLY Position: Q2 2026 in Review

Commonwealth Financial Services increased its Eli Lilly (LLY) stake by 16% in Q2 2026, buying an estimated $169K and bringing the position to 1,214 shares worth $1.46M. The position accounts for 0.2% of the portfolio, ranked #81.

Commonwealth Financial Services first reported a position in LLY in Q4 2014 and has held it in 22 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Commonwealth Financial Services held 1,214 shares of Eli Lilly worth $1.46M as of Q2 2026.
  • Commonwealth Financial Services bought 165 Eli Lilly shares in Q2 2026, an estimated $169K.
  • Eli Lilly made up 0.2% of Commonwealth Financial Services's portfolio in Q2 2026, its #81 holding.
  • Commonwealth Financial Services first reported a position in Eli Lilly in Q4 2014 and has held it in 22 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Commonwealth Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.